Zapping the brain without surgery: new method targets deep regions

NCT ID NCT07215299

First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 33 times

Summary

This study tests a new non-invasive brain stimulation technique called temporal interference (TI) that uses scalp electrodes to safely reach deep brain areas. Researchers will scan the brains of 30 healthy volunteers to see if TI can activate the nucleus accumbens without affecting the outer brain. The goal is to understand brain function and lay the groundwork for future treatments for addiction, OCD, and Parkinson's.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Indiana University Bloomington, Imaging Research Facility

    RECRUITING

    Bloomington, Indiana, 47408, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Temporal Interference (TI) Electrical Stimulation

What this could lead to

If successful, this could pave the way for non-invasive treatments for conditions like addiction, OCD, and Parkinson's disease.

What could go wrong

This is an early-stage study in 30 healthy volunteers, so it may not translate to clinical benefits. The technology is still experimental.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.